"We partner for patients by unlocking public-private partnerships among public health, health care, and community and free data to enable innovation and empower health equity." — Judy Monroe, President and CEO, CDC Foundation To build on...

"To go back to the way things were risks not only being unprepared for the next pandemic but also losing this opportunity to set a new course for medical discovery." — Gary Michelson, Founder and Co-Chair, Michelson Medical Research...

"To channel cross-sector knowledge, courage, and urgency so we can turn ‘disease care’ into health care: Tomorrow is built today—let’s intercept diseases before they do harm!" — Wen Hwa Lee, CEO and Chief Scientist, Action Against Age...

“It is the willingness of ordinary people across Africa to step up and do the right things—from social distancing to new sanitary habits—that has kept the virus contained.” The first case of COVID-19 in Africa was confirmed in Egypt on...

When every member of the United Nations signed on to the Astana Declaration in October 2018, it offered a new commitment to making comprehensive primary care available and accessible to all—to every single person, irrespective of relative...

The following is an excerpt from the book Uncontrolled Spread by Scott Gottlieb, MD. Copyright ©2021 by Scott Gottlieb. Published with permission by Harper, an imprint of HarperCollins Publishers. The traditional planning for pandemics had...

Innovations in cancer therapeutics and precision diagnostics impact countless lives as more and more cancer patients are able to claim the title of cancer survivor. While we applaud this progress, for too many patients innovation has not...

1. Support evidence-based medicine: A key problem during the second wave of COVID-19 infection was medication misuse. Numerous drugs, none proven effective against COVID-19, were prescribed extensively, even prophylactically, in some states...

Singapore is poised to achieve at least 80–85 percent vaccine coverage against SARS-CoV-2 by the end of September 2021. Excluding children aged 12 and below, this would mean that at least 90–95 percent of the eligible population are...

As we members of the biopharmaceutical industry look to the post-COVID-19 world, we can draw lessons from both the successes and failures of the world’s responses to this global crisis. If there is a silver lining to the pandemic experience...